DigestRedComo funciona
Red
/
Empresas
Im
No verificado

Immunomic Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa
20/07/2026
Ciencia
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
Medicina - Varios
Industria
Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000
Fuente
Immunomic Therapeutics, Inc.
Editor
Business Wire
1.00
0
15/06/2026
Industria
Sanidad
Ciencia
Farmacéutica
Oncología
Material médico sanitario
Medicina - Varios
Biotecnología
Higiene alimentaria
Salud
ITI Announces PMDA Clearance of CTN for a UNITE®-Based Self-Amplifying RNA Treatment for Japanese Red Cedar Allergy
Fuente
Immunomic Therapeutics, Inc.
Editor
Business Wire
1.00
0
20/01/2026
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
Industria
Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in Combination with Keytruda®
Fuente
Immunomic Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/11/2024
Eventos
Industria
Oncología
Salud
VIH, SIDA y enfermedades autoinmunes
Sanidad
Farmacéutica
Biotecnología
Immunomic Therapeutics Announces Presentation on Self-amplifying RNA vaccines using the UNITE® platform for Triple-negative Breast Cancer at SITC 39th Annual Meeting 2024
Fuente
Immunomic Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0